A.M. Edition for Feb. 9. The latest revelations from the Epstein files bring down the top aide to Britain’s prime minister. Will Keir Starmer be next? WSJ U.K. correspondent Max Colchester weighs in. Plus, Novo Nordisk shares are rallying after the U.S. Food and Drug Administration threatened to restrict access to the ingredients needed for knockoffs of popular GLP-1 medicines like Wegovy. And SpaceX delays its Mars plans to focus on the moon instead. Luke Vargas hosts.
Sign up for the WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices